The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(5-(5-carbamimidoylpyridin-2-yl)furan-2-yl)picolinimidamide ID: ALA1650579
PubChem CID: 53324541
Max Phase: Preclinical
Molecular Formula: C16H14N6O
Molecular Weight: 306.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: DB1283 | CHEMBL1650579|DB1283
Canonical SMILES: N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)nc3)o2)nc1
Standard InChI: InChI=1S/C16H14N6O/c17-15(18)10-2-3-11(21-8-10)14-6-5-13(23-14)9-1-4-12(16(19)20)22-7-9/h1-8H,(H3,17,18)(H3,19,20)
Standard InChI Key: WSEZUZSOMAOMKF-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-3.7233 -16.4678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7245 -17.2954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0116 -17.7082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2922 -17.2948 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2954 -16.4638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0135 -16.0549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5072 -16.2131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8425 -16.7016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1724 -16.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4229 -15.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2479 -15.4299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5422 -16.6260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5463 -17.4521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2626 -17.8599 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9753 -17.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9672 -16.6134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2503 -16.2095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6930 -17.8495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6995 -18.6745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4041 -17.4314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4396 -17.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1535 -17.2933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4408 -18.5318 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 7 1 0
5 6 2 0
6 1 1 0
12 13 2 0
7 8 1 0
13 14 1 0
1 2 2 0
14 15 2 0
3 4 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 12 1 0
4 5 1 0
15 18 1 0
2 3 1 0
18 19 1 0
8 9 1 0
18 20 2 0
9 10 2 0
2 21 1 0
10 11 1 0
21 22 2 0
11 7 2 0
21 23 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 306.33Molecular Weight (Monoisotopic): 306.1229AlogP: 1.97#Rotatable Bonds: 4Polar Surface Area: 138.66Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.98CX LogP: 0.43CX LogD: -2.86Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.43Np Likeness Score: -0.74
References 1. Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R.. (2009) In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model., 53 (12): [PMID:19786604 ] [10.1128/aac.00422-09 ]